Article Versions Notes

Yu F, Gao Y, Wu Y, Dai A, Wang X, Zhang X, Liu G, Xu Q, Chen D. Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells. Cancers. 2022; 14(19):4947. https://doi.org/10.3390/cancers14194947

Yu, Feng, Yang Gao, Yan Wu, Anran Dai, Xiaoyan Wang, Xiangzhi Zhang, Guodong Liu, Qinggang Xu, and Dongfeng Chen. 2022. "Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells" Cancers 14, no. 19: 4947. https://doi.org/10.3390/cancers14194947

Yu, F., Gao, Y., Wu, Y., Dai, A., Wang, X., Zhang, X., Liu, G., Xu, Q., & Chen, D. (2022). Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells. Cancers, 14(19), 4947. https://doi.org/10.3390/cancers14194947